ERISA Ledger · U.S. DOL EBSA Form 5500 (2024)

Rigel Pharmaceuticals INC.

Official 2024 U.S. DOL Form 5500 summary for Rigel Pharmaceuticals INC. (Rigel Pharmaceuticals INC. 401k Plan · EIN 94-3248524 · PN 001): $64.26M net assets, 164 active participants, and $4.19 per $10,000 (4.19 bps).

Reported Form 5500 Fee & Service Summary

Plan SponsorRigel Pharmaceuticals INC.
Filing IdentifierRigel Pharmaceuticals INC. 401k Plan · EIN 94-3248524 · PN 001
Plan Category & State401(k) Defined Contribution (CA)
Asset-Size Peer Cohort$25M-$100M
Plan Net Assets (2024)$64.26M
Active Participants164
Direct Admin Fee Rate$4.19 per $10,000 (4.19 bps)
Cohort Peer Median$19.23 per $10,000 (19.23 bps)
Primary Recordkeeper / ProviderFidelity Investments
Schedule H Line 4a RemittanceTimely Employer Remittance (0 reported on Line 4a)

Browse all 78,373 plans & Schedule C vendors · Methodology · Meru AI